HEMISPHERX BIOPHARMA INC

Q: Jun 30 2026

Q: Mar 31 2026

FY: Dec 31 2025

Q: Sep 30 2025

Q: Sep 30 2025

Q: Jun 30 2025

Q: Mar 31 2025

FY: Dec 31 2024

Q: Sep 30 2024

Q: Jun 30 2024

Q: Mar 31 2024

FY: Dec 31 2023

Q: Sep 30 2023

Q: Jun 30 2023

Q: Mar 31 2023

FY: Dec 31 2022

Q: Sep 30 2022

Q: Jun 30 2022

Q: Mar 31 2022

FY: Dec 31 2021

Entry into a Material Definitive Agreement

Entry into a Material Definitive Agreement

Entry into a Material Definitive Agreement

Regulation FD Disclosure

Results of Operations and Financial Condition

Entry into a Material Definitive Agreement

Termination of a Material Definitive Agreement

Submission of Matters to a Vote of Security Holders

Other Events

Entry into a Material Definitive Agreement

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Regulation FD Disclosure

Entry into a Material Definitive Agreement

Entry into a Material Definitive Agreement

Regulation FD Disclosure

Unregistered Sales of Equity Securities

Entry into a Material Definitive Agreement

Entry into a Material Definitive Agreement

Entry into a Material Definitive Agreement

Regulation FD Disclosure

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Registration (IPO) statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Prospectus Supplement for Primary Offering

Registration (IPO) statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement with Pricing Information

Amended Initial Registration Statement

Notice of Effectiveness

Amended Initial Registration Statement

Amended Initial Registration Statement

Registration (IPO) statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Definitive Proxy Statement

Definitive Proxy Statement

Preliminary Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Preliminary Proxy Statement

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Additional proxy soliciting materials filed by a non-management party

Additional proxy soliciting materials filed by a non-management party

Additional Information for Proxy Statement/ Votes

Additional proxy soliciting materials filed by a non-management party

Additional proxy soliciting materials filed by a non-management party

Additional proxy soliciting materials filed by a non-management party

Additional Information for Proxy Statement/ Votes

Additional proxy soliciting materials filed by a non-management party

Additional proxy soliciting materials filed by a non-management party

Additional Information for Proxy Statement/ Votes

Additional proxy soliciting materials filed by a non-management party

Additional Information for Proxy Statement/ Votes

Equels Thomas K

Equels Thomas K

Equels Thomas K

Equels Thomas K

INTRACOASTAL CAPITAL, LLC

Orca Capital AG

CHEMEROW DAVID I.

Equels Thomas K

CHEMEROW DAVID I.

Equels Thomas K

CHEMEROW DAVID I.

KELLNER TED D

Equels Thomas K

Equels Thomas K

MITCHELL WILLIAM M

Equels Thomas K

KELLNER TED D

Equels Thomas K

Rodino Peter W III

CHEMEROW DAVID I.

Annual Report Scanned (Paper)

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC